Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production

Blood

Volumn 101, Issue 2, 2003, Pages 611-620

  Morelli, Adrian E ^a   Larregina, Adriana T ^a   Shufesky, William J ^a   Zahorchak, Alan F ^a   Logar, Alison J ^a   Papworth, Glenn D ^a   Wang, Zhiliang ^a   Watkins, Simon C ^a   Falo Jr , Louis D ^a   Thomson, Angus W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; CELL ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C4 RECEPTOR; COMPLEMENT FACTOR I; COMPLEMENT RECEPTOR; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; OPSONIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOTIC CELL; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL LEVEL; CELL MIGRATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HYPOCOMPLEMENTEMIA; IMMUNOLOGICAL TOLERANCE; INTERNALIZATION; LEUKOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SPLEEN; T LYMPHOCYTE;

EID: 0037438495     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1769     Document Type: Article

References (56)

1. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med. 2000;191:411-416.
2. 3 integrin and requires intracellular and extracellular calcium. Eur J Immunol. 1997;27:1893-1900.
3. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392:86-89.
4. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998;188:1359-1368.
5. Parr MB, Kepple L, Parr EL. Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol Reprod. 1991;45:252-260.
6. Huang F-P, Platt N, Wykes M, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 2000;191:435-443.
7. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999;5:1249-1255.
8. Sauter B, Albert M, Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 2000;191:423-433.
9. Stuart LM, Lucas M, Simpson C, et al. Inhibitory effects of apoptotic cell ingestion upon endotoxindriven myeloid dendritic cell maturation. J Immunol. 2002;168:1627-1635.
10. 2. J Leuk Biol. 1992;52:269-273.
11. Voll RE, Herrmann M, Roth EA, et al. Immunosuppressive effects of apoptotic cells. Nature. 1997;390:350-351.
12. Fadok VA, McDonald PP, Bratton DL, Henson PM. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans. 1998;26:653-656.
13. Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J Clin Invest. 1998;101:890-898.
14. McDonald PP, Fadok VA, Bratton D, Henson PM. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J Immunol. 1999;163:6164-6172.
15. Takizawa F, Tsuji S, Nagasawa S. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett. 1996;397:269-272.
16. Mevorach D, Mascarenhas JO, Gershow D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med. 1998;188:2313-2320.
17. Hammerberg C, Katiyan SK, Carrol MC, Cooper K. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J Exp Med. 1998;187:1133-1138.
18. Inaba K, Pack M, Inaba M, et ar al. High levels of a major histocompatibility complex Il-11-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J Exp Med. 1997;186:665-672.
19. Inaba K, Turley S, Yamaide F, et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex II products on dendritic cells. J Exp Med. 1998;188:2163-2173.
20. Morelli AE, Zahorchak AF, Larregina AT, et al. Regulation of cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by LPS or CD40 ligation. Blood. 2001;98:1512-1523.
21. Bianco C, Patrick R, Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes, I: separation and characteristics. J Exp Med. 1971;132:702-720.
22. Beller DI, Springer TA, Schreiber RD. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med. 1982;156:1000-1009.
23. Ross G. Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. J Immunol Methods. 1980;37:197-211.
24. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med. 2002;195:1289-1302.
25. Murphy DB, Lo D, Rath S et al. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature. 1989;338:765-768.
26. Pulendran B, Lingappa J, Kennedy MK, et al. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol. 1997;159:2222-2231.
27. Leenen PJM, Radosevic K, Voerman JSA, et al. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol. 1998;160:2166-2173.
28. + dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation. Blood. 2002;99:999-1004.
29. Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781-795.
30. Driessens MHE, van Hulten P, Zuurbier A, La Riviere G, Roos E. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18: evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct. J Leuk Biol. 1996;60:758-765.
31. Van derBerg CW, Aerts PC, Dijk HV. In vivo anticomplementary activities of the cobra venom factors from Naja naja and Naja haje. J Immunol Methods. 1991;136:287-294.
32. Sutterwala F, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med. 1997;185:1977-1985.
33. Marth T, Kelsall BL. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med. 1997;185:1987-1995.
34. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med. 1998;187:1555-1564.
35. Kurts C, Kosaka H, Carbone FR, Miler JF, Heath WR. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med. 1997;186:239-245.
36. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000;192:1213-1222.
37. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in human after injection of immature dendritic cells. J Exp Med. 2001;193:233-238.
38. Roncarolo M-G, Levings MK, Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J Exp Med. 2001;193:F5-F9.
39. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769-779.
40. Morelli AE, Hackstein H, Thomson AW. Potential of tolerogenic dendritic cells for transplantation. Semin Immunol. 2001;13:323-335.
41. Steinman RM, Pack M, Inaba I. Dendritic cell in the T-cell areas of lymphoid organs. Immunol Rev. 1997;156:25-37.
42. Leenen PJM, Radosevic K, Voerman JSA, et al. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol. 1998;160:2166-2173.
43. + T cells produce active immune unresponsiveness. J Immunol. 2002;168:5589-5595.
44. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407:784-788.
45. Gregory CD. CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol. 2000;12:27-34.
46. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 1997;61:375-380.
47. Fadok VA, Bratton DL, Guthrie L, Henson PM. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol. 2001;166:6847-6854.
48. Korb LC,Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol. 1997;158:4525-4528.
49. Rosen H, Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocylic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med. 1987;166:1685-1701.
50. Ren Y, Stuart L, Lindberg FP, et al. Nonphlogistic clearance of late apoptotic neutrophils by macrophages: efficient phagocytosis independent of β2 integrins. J Immunol. 2001;166:4743-4750.
51. Armant M,Avice M-N, Hermann P, et al. CD47 ligation selectively downregulates human interleukin 12 production. J Exp Med. 1999;190:1175-1181.
52. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz AB, Henson P. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000;405:85-90.
53. Demeure CE, Tanaka H, Mateo V. Rubio M, Delespese G, Sarfati M. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J Immunol. 2000;164:2193-2199.
54. Urban BC, Willcox N, Roberts DJ. A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci U S A. 2001;98:8750-8755.
55. Yoshida Y, Kang K, Berger M, et al. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol. 1998;161:5873-5879.
56. De Carvalho Bittencourt M, Perruche S, Contassot E, et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood. 2001;98:224-230.